Cornell researchers have discovered a way to penetrate the blood brain barrier (BBB) that may soon permit delivery of drugs directly into the brain to treat disorders such as Alzheimer’s disease and chemotherapy-resistant cancers. The BBB is a layer of endothelial cells that selectively allow entry of molecules needed for brain function, such as amino acids, oxygen, glucose and water, while keeping others out. An FDA-approved drug, Lexiscan activates adenosine receptors – that are expressed on these BBB cells.
“We can open the BBB for a brief window of time, lo...
Read More
Recent Comments